We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
URSODOX GH/ URSODOX LAPL (Generic Health Pty Ltd)
Product name
URSODOX GH/ URSODOX LAPL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
168 (255 working days)
Active ingredients
Ursodeoxycholic acid
Registration type
New generic medicine
Indication
URSODOX LAPL/ URSODOX GH capsules are indicated in the treatment of chronic cholestatic liver diseases.